Mobidiag
Mobidiag is a fast-growing molecular diagnostics company whose rapid, cost-effective, widely applicable and robust technology makes the power of molecular diagnostics available to address the spread of infectious diseases and antimicrobial resistance (AMR) by rapid detection of pathogens and their potential resistance to antibiotics. Through its Amplidiag® and Novodiag® solutions, Mobidiag offers a comprehensive range of molecular diagnostic solutions for the detection of infectious diseases to laboratories of all sizes. Mobidiag is headquartered in Espoo, Finland, with subsidiaries in France, UK and Sweden.
Last updated on
About Mobidiag
Founded
2000Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$35MCategory
Industry
BiotechnologyLocation
City
EspooState
UusimaaCountry
FinlandMobidiag
Find your buyer within Mobidiag